Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.

MLA

Maraldo, M. V., et al. “Estimated Risk of Cardiovascular Disease and Secondary Cancers with Modern Highly Conformal Radiotherapy for Early-Stage Mediastinal Hodgkin Lymphoma.” Annals of Oncology, vol. 24, no. 8, Aug. 2013, pp. 2113–18. EBSCOhost, https://doi.org/10.1093/annonc/mdt156.

APA

Maraldo, M. V., Brodin, N. P., Aznar, M. C., Vogelius, I. R., Munck af Rosenschöld, P., Petersen, P. M., & Specht, L. (2013). Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Annals of Oncology, 24(8), 2113–2118. https://doi.org/10.1093/annonc/mdt156

Chicago

Maraldo, M. V., N. P. Brodin, M. C. Aznar, I. R. Vogelius, P. Munck af Rosenschöld, P. M. Petersen, and L. Specht. 2013. “Estimated Risk of Cardiovascular Disease and Secondary Cancers with Modern Highly Conformal Radiotherapy for Early-Stage Mediastinal Hodgkin Lymphoma.” Annals of Oncology 24 (8): 2113–18. doi:10.1093/annonc/mdt156.